Requirement of p34(cdc2) kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1β-converting enzyme-related proteases

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4551-4555

  Yao, Siu Long ^a   McKenna, Karen A ^a   Sharkis, Saul J ^a   Bedi, Atul ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; CYCLIN DEPENDENT KINASE 1; CYSTEINE PROTEINASE; FAS ANTIGEN; LIPOPROTEIN RECEPTOR; PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; DRUG EFFECT; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANTIGENS, CD95; APOPTOSIS; CASPASE 1; CDC2 PROTEIN KINASE; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; GENETIC VECTORS; HUMANS; JURKAT CELLS; PROTEIN KINASES; RECEPTORS, LIPOPROTEIN; TRANSFECTION;

EID: 0029661896     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Nagata, S , and Golstein, P. The Fas death factor. Science (Washington DC), 267: 1449-1456, 1995.
2. Crispe, I N. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity, 1: 347-349, 1994.
3. Muzio, M., Chinnaiyan, A. M , Kischkel, F. C., O'Rourke, K , Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M , Krammer, P. H., Peter, M. E., and Dixit, V M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95(Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996
4. Enari, M., Hug, H , and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995
5. Los, M., Van de Craen, M., Penning, L. C , Schenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (Lond), 375: 81-83, 1995
6. Enari, M., Talanian, R V., Wong, W W., and Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond), 380: 723-726, 1996.
7. Thornberry, N A., Bull, H. G., Calaycay, J. R., Chapman, K. T , Howard, A. D., Kostura, M J., Miller, D. K., Molineaux, S. M., Weidner, J R , Aunins, J., Elliston, K O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. J -F , Egger, L. A., Gaffney, E. P , Limjuco, G., Palyha, O. C., Raju, S M , Ralando, A M., Salley, J. P., Yamin, T. T., Lee, T. D., Shivley, J. E , MacCross, M , Mumford, R. A., Schmidt, J. A , and Tocci, M. J. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature (Lond), 356: 768-774, 1992.
8. Yuan, J , Shaham, S , Ledoux, S., Ellis, H. M., and Horvitz, H R The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75 641-652, 1993
9. Tewari, M., Quan, L. T , O'Rourke, K., Desnoyers, S , Zeng, Z , Beidler, D. R., Poirer, G. G , and Dixit, V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase Cell, 81: 801-809, 1995.
10. Nicholson, D W , Ali, A., Thornberry, N A , Vaillancourt, J. P., Ding, C. K , Gallant, M., Gareau, Y , Griffin, P. R., Labelle, M , Lazebnik, Y. A., Munday, M A., Raju, S. M., Smulson, M. E., Yamin, T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature (Lond), 376: 37-43, 1995.
11. Heusel, J. W., Wesselschmidt, R. L , Shresta, S., Russell, J. H., and Ley, T J Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells Cell, 76: 977-987, 1994.
12. Darmon, A. J., Nicholson, D. W , and Bleackley, R. C Activation of the apoptotic protease CPP32 by cytotoxic T-cell derived granzyme B. Nature (Lond), 377: 446-448, 1995.
13. cdc2 activation required for apoptosis Science (Washington DC), 263: 1143-1145, 1994.
14. Heald, R , McLoughlin, M., and McKeon, F Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell, 74: 463-474, 1993.
15. van den Heuvel, S , and Harlow, E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science (Washington DC), 262: 2050-2054, 1993
16. cdc2 exclusively on Tyr15. EMBO J., 12: 75-85, 1993.
17. Fraser, A., and Evan, G. A license to kill. Cell, 85: 781-784, 1996.
18. Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp. Med., 183: 1957-1964, 1996.
19. Nishioka, W. K., and Welsh, R. M. Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target J. Exp. Med , 179: 769-774, 1994.
20. Fotedar, R., Flatt, J., Gupta, S., Margolis, R. L., Fitzgerald, P., Messier, H., and Fotedar, A Activation induced T cell death is cell cycle dependent and regulated by cyclin B Mol. Cell Biol., 15: 932-942, 1994.
21. Meikrantz, W., Gisselbrecht, S., Tam, S. W., Schlegel, R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl Acad. Sci. USA, 91: 3754-3758, 1994.
22. Shimizu, T , O'Connor, P. M , Kohn, K. W , Pommier, Y. Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res , 55: 228-231, 1995.
23. Li, C. J., Friedman, D J., Wang, C , Metelev, V , Pardee, A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein Science (Washington DC), 268 429-431, 1995.
24. cdc2 kinase. Nat. Med., in press, 1996.
25. cdc2 kinase. Proc. Am Assoc. Cancer Res., 37: 24, 1996.
26. cdc2 and apoptosis. Science (Washington DC), 268: 106-107, 1995.
27. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267; 1456-1462, 1995.